There are reports that Eli Lilly provided a 79-year-old patient with access to its obesity drug, but the identity of the patient is unclear. The White House has denied that the patient is a specific individual, while some outlets are investigating the claim that this person may be a well-known figure. The situation has sparked questions and an investigation into who received the special access to the unapproved drug.